Home Exercise to Enhance Mobility for Older Diabetics
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01308008 |
|
Recruitment Status :
Completed
First Posted : March 3, 2011
Results First Posted : November 8, 2018
Last Update Posted : November 8, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Diabetes Mellitus Type 2 | Behavioral: home exercise/physical activity (PA) enhancement program with behavioral support Behavioral: flex and toning health education program | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 144 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Home Program to Enhance Mobility in Older Veteran Diabetics |
| Study Start Date : | November 2011 |
| Actual Primary Completion Date : | May 2016 |
| Actual Study Completion Date : | August 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Functional exercise- home physical activity
On-site personal trainer-based functional aerobic program followed by home intervention consisting of functional exercise training and enhanced physical activity with telephonic behavioral support
|
Behavioral: home exercise/physical activity (PA) enhancement program with behavioral support
Initial on-site personal trainer-based functional aerobic program followed by home intervention consisting of functional exercise training and enhanced physical activity with nurse telephonic behavioral support |
|
Active Comparator: Flex and tone- home health education
Initial on-site flex and toning program continued on follow-up along with health education
|
Behavioral: flex and toning health education program
Initial flex and toning program continued on follow-up along with health education |
- Comfortable Gait Speed [ Time Frame: 1 year ]Gait velocity over 6 meters
- Six Minute Walk Distance [ Time Frame: one year ]Walk distance covered in feet over 6 minutes
- Physical Activity [ Time Frame: one year ]Average physical activity counts per waking minute
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Sedentary
- Type 2 Diabetes
- No medical contraindications to exercise
Exclusion Criteria:
- Enrolled in intensive exercise program
- Unable to cooperate with protocol (e.g. cognitive impairment)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01308008
| United States, Michigan | |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | |
| Ann Arbor, Michigan, United States, 48105 | |
| Principal Investigator: | Neil Alexander, MD | VA Ann Arbor Healthcare System, Ann Arbor, MI |
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT01308008 |
| Other Study ID Numbers: |
E7547-R |
| First Posted: | March 3, 2011 Key Record Dates |
| Results First Posted: | November 8, 2018 |
| Last Update Posted: | November 8, 2018 |
| Last Verified: | November 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Type 2 Diabetes Mellitus Mobility Limitation |
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |

